Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-01-07 14:12:29
Reporting Period:
Accepted Time:
2020-01-07 14:12:29
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1492674 T2 Biosystems Inc. TTOO () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292650 B David Elsbree 101 Hartwell Avenue
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-03 5,316 $1.16 91,081 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000 Indirect By spouse
  1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2019, to cover payment of tax liability incident to the vesting of restricted stock units.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.14 to $1.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.